Literature DB >> 27709453

Commentary on "Statistical Approaches to Assess Biosimilarity from Analytical Data" by Burdick et al [1].

Yi Tsong1, Qi Xia2, Yu-Ting Weng3.   

Abstract

Keywords:  biosimilarity; variance component model

Mesh:

Substances:

Year:  2016        PMID: 27709453     DOI: 10.1208/s12248-016-9987-x

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


× No keyword cloud information.
  3 in total

1.  Adjustment for unbalanced sample size for analytical biosimilar equivalence assessment.

Authors:  Xiaoyu Cassie Dong; Yu-Ting Weng; Yi Tsong
Journal:  J Biopharm Stat       Date:  2017-01-06       Impact factor: 1.051

2.  Statistical considerations regarding correlated lots in analytical biosimilar equivalence test.

Authors:  Meiyu Shen; Tianhua Wang; Yi Tsong
Journal:  J Biopharm Stat       Date:  2016-12-01       Impact factor: 1.051

3.  Wald tests for variance-adjusted equivalence assessment with normal endpoints.

Authors:  Yue-Ming Chen; Yu-Ting Weng; Xiaoyu Dong; Yi Tsong
Journal:  J Biopharm Stat       Date:  2016-12-01       Impact factor: 1.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.